How metoclopramide affects stomach contents in diabetes mellitus patients before surgery for elective procedures

Effect of metoclopramide on gastric residual volume as measured by ultrasonography in diabetes mellitus patients undergoing elective surgeries: A randomized controlled study - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/077793

Enrollment

Registered

2024-12-06

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: group A- diabetes mellitus patients will receive metoclopramide: Diabetes mellitus patients posted for elective surgeries will be kept nil per oral for 8 hrs. Baseline HbA1c , fasting b

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients between 18 and 65 years of age of either gender. ASA-PS 2 or 3 patients with diabetes mellitus scheduled for elective surgeries under general anaesthesia.

Exclusion criteria

Exclusion criteria: Patients who are not willing to give consent. patients with partial and total gastrectomies. Patients undergoing gastro-intestinal surgeries. patients who are allergic to study drug(metoclopramide) patients who have increased intracranial pressure. patients who are unable to lie in the right lateral decubitus position. Factors responsible for gastroparesis other than diabetes mellitus (like pregnancy, hypothyroidism, multiple sclerosis) Those who are on medications like opioids, anti-depressants, anti-cholinergics

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of metoclopramide on gastric residual volume as measured by ultrasonography in diabetes mellitus patients undergoing elective surgeriesTimepoint: gastric residual volume measured before and 30 mins after administering drug or normal saline and just before extubation also.	—

Secondary

Measure	Time frame
To grade the aspiration risk by measuring gastric residual volume in diabetes mellitus patients. To compare post operative nausea , vomiting, regurgitation and aspiration among two groups. To assess whether any change in anaesthesia and airway plan based on gastric residual volume.Timepoint: post operative nausea, vomiting, regurgitation and aspiration assessed at 6 hrs,12 hrs and 24 hrs.	—

Countries

India

Contacts

Public ContactDr Hari Haran N

All India Institute of Medical Sciences, Bathinda

mayankgupta6682@gmail.com09655601229

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 27, 2026